Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × talazoparib × Tumor-Agnostic × Clear all

Phase

Phase 2 5 Phase 1 3 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Blood Specimen Collection 24 Standard of Care 22 Surveys and Questionnaires 16 Methods 14 Educational Status 13 Interviews as Topic 11 Radiosurgery 10 Exercise 10 Biopsy 10 Practice Guidelines as Topic 9 Magnetic Resonance Spectroscopy 9 Early Intervention, Educational 9 Radiotherapy 8 Palliative Care 8 Therapeutics 7 Music Therapy 7 Control Groups 7 Positron Emission Tomography Computed Tomography 6 Patient Navigation 5 Fluorodeoxyglucose F18 5 Telemedicine 4 Geriatric Assessment 4 Art Therapy 4 Yoga 3 Sunitinib 3 Quality of Life 3 Psychiatric Rehabilitation 3 Mindfulness 3 Meditation 3 Health 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡